152 related articles for article (PubMed ID: 2418482)
21. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
[TBL] [Abstract][Full Text] [Related]
22. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies and the biological approach to cancer.
Carter PW
J Biol Response Mod; 1985 Aug; 4(4):325-39. PubMed ID: 4031950
[No Abstract] [Full Text] [Related]
24. CEA-related antigens: molecular biology and clinical significance.
Shively JE; Beatty JD
Crit Rev Oncol Hematol; 1985; 2(4):355-99. PubMed ID: 3886178
[No Abstract] [Full Text] [Related]
25. CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas.
Prat M; Morra I; Bussolati G; Comoglio PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998
[TBL] [Abstract][Full Text] [Related]
26. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
Wu JT; Miya T; Knight JA; Knight DP
Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
[TBL] [Abstract][Full Text] [Related]
27. [Thomsen antigen in human normal and tumor tissues].
Berdinskikh MS; Pavliuchenkova RP; Kiseleva AS; Kulakova AM; Kosiakov PN
Biull Eksp Biol Med; 1983 Mar; 95(3):59-61. PubMed ID: 6830988
[TBL] [Abstract][Full Text] [Related]
28. Detection of carcinoembryonic antigen and related antigens in sera of patients with gastrointestinal tumors using monoclonal antibodies in double-determinant radioimmunoassays.
Herlyn M; Blaszczyk M; Sears HF; Verrill H; Lindgren J; Colcher D; Steplewski Z; Schlom J; Koprowski H
Hybridoma; 1983; 2(3):329-39. PubMed ID: 6205981
[TBL] [Abstract][Full Text] [Related]
29. [T antigen and CEA; comparison between 2 tumor markers in breast cancer and malignant gynecologic neoplasms].
Scheiffarth OF
Arch Gynecol; 1979 Jul; 228(1-4):659-60. PubMed ID: 485546
[No Abstract] [Full Text] [Related]
30. Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens.
Fink LM; Clarke SM
Prog Clin Pathol; 1984; 9():121-33. PubMed ID: 6364219
[No Abstract] [Full Text] [Related]
31. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
Forti E; Wolf D; Melia M
Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
[No Abstract] [Full Text] [Related]
32. Markers in breast and lung cancer.
Coombes RC; Dearnaley DP; Ellison ML; Neville AM
Ann Clin Biochem; 1982 Jul; 19 (Pt 4)():263-8. PubMed ID: 6127052
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
Steffens J; Friedmann W; Lobeck H
Urol Res; 1985; 13(2):55-9. PubMed ID: 2409654
[TBL] [Abstract][Full Text] [Related]
34. [Serum carbohydrate 19-9 Tm and bronchial cancer. Comparative study with another tumor marker, carcinoembryonic antigen].
Bisset JP; Kleisbauer JP; Roux F; Treffot MJ
Pathol Biol (Paris); 1985 Jun; 33(6):672-6. PubMed ID: 3900886
[TBL] [Abstract][Full Text] [Related]
35. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.
Ghosh AK; Gatter KC; Dunnill MS; Mason DY
J Clin Pathol; 1987 Jan; 40(1):19-25. PubMed ID: 2434531
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic significance of tumor markers.
von Kleist SU
Cancer Res; 1980 Aug; 40(8 Pt 2):2977-8. PubMed ID: 6156757
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies raised against NeuAc alpha 2-6neolactotetraosylceramide detect carcinoma-associated gangliosides.
Nilsson O; Lindholm L; Holmgren J; Svennerholm L
Biochim Biophys Acta; 1985 Jul; 835(3):577-83. PubMed ID: 2410031
[TBL] [Abstract][Full Text] [Related]
38. Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases.
Eerdekens MW; Nouwen EJ; Pollet DE; Briers TW; De Broe ME
Clin Chem; 1985 May; 31(5):687-90. PubMed ID: 3857128
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
Staab HJ; Hornung A; Anderer FA; Kieninger G
Dtsch Med Wochenschr; 1984 Jul; 109(30):1141-7. PubMed ID: 6204834
[TBL] [Abstract][Full Text] [Related]
40. International conference on human tumor markers. Biological basis and clinical relevance. Munich, Germany FR June 17-20, 1982. Abstracts.
Cancer Detect Prev; 1982; 5(2):231-81. PubMed ID: 7127344
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
